Quantum Design announces exclusive distribution agreement for NanoView’s ExoView® platform in China

NanoView Biosciences and Quantum Design China, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView® platform in China.

“We are pleased to offer customers in China access to the ExoView platform, which allows scientists the unprecedented ability to accurately identify and characterize extracellular vesicles, including exosomes and viruses” said Lamber Cao, General Manager of Quantum Design China. “We look forward to working closely with the NanoView team to introduce this unique technology to the rapidly expanding field of nanomedical research.”

The ExoView platform provides high-resolution sizing, counting and phenotyping of exosomes and viral vectors at the individual extracellular vesicle level. Understanding the molecules carried by extracellular vesicles has potential for diagnostic, prognostic, and therapeutic use for a broad range of diseases. The ExoView platform requires low sample input, no extensive sample preparation or purification, and minimal hands-on time. It can be used directly with complex biological samples.

“We are excited to work with Quantum Design China, and further expand our distribution relationship in Asia with Quantum Design International,” said Jerry Williamson, CEO of NanoView Biosciences. “Accurate extracellular vesicle characterization is a critical step forward in precision nanomedicine, and our goal is to enable that progress with our one-of-a-kind products which allow researchers to better understand the function and utility of these important biological nanoparticles.”

Source – PR Newswire

Leave a Reply

Your email address will not be published. Required fields are marked *